LifeMD (LFMD) vs Nakamoto (NAKA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
LifeMD (LFMD) has outperformed Nakamoto (NAKA) over the past year, losing 62.5% versus a loss of 80.6%. LifeMD is the larger company by market cap ($69.8 million vs $63.1 million), about 1.1 times the size. LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -2867.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFMD | NAKA |
|---|---|---|
| Share price | $1.45 | $3.44 |
| Market cap | $69.84M | $63.11M |
| 1-day change | -9.40% | -15.89% |
| YTD return | -57.62% | -75.50% |
| 1-year return | -62.47% | -80.59% |
| 5-year return | -65.92% | — |
| P/E ratio (TTM) | — | 0.14 |
| Forward P/E | 9.32 | — |
| EPS (TTM) | $-0.52 | $24.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $194.06M | $1.82M |
| Revenue growth (YoY) | +25.34% | -33.04% |
| Net income (latest FY) | $14.35M | $-52.23M |
| Gross margin | 85.72% | — |
| Operating margin | -3.95% | -10824.01% |
| Net margin | 7.40% | -2867.65% |
| 52-week high | $5.38 | $23.20 |
| 52-week low | $1.38 | $3.33 |
| Distance from 52-week high | -73.14% | -85.17% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +462.63% | +287.50% |
| Average volume | 929.40K | 197.37K |
| Shares outstanding | 48.33M | 18.35M |
| Employees | 347 | 33 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFMD has outperformed NAKA by 18.1 percentage points over the past year.
- LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -2867.6 cents for Nakamoto.
- LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -33.04%).
About LifeMD
LFMD stock →LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Health Care · Medical/Nursing Services · 347 employees
About Nakamoto
NAKA stock →Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies.
Health Care · Medical/Nursing Services · 33 employees
LFMD vs NAKA FAQ
Which is bigger, LifeMD or Nakamoto?
LifeMD (LFMD) is larger, with a market capitalization of $69.84M compared with $63.11M for Nakamoto (NAKA).
Which stock has performed better over the past year, LFMD or NAKA?
LFMD returned -62.47% over the past 12 months, compared with -80.59% for NAKA (price return, excluding dividends). Past performance does not predict future results.
Are LifeMD and Nakamoto in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.